Immortalized Hepatocytes Using Human Artificial Chromosome
Authors: Ito, Masahiro1; Ito, Ryoutaro1; Yoshihara, Daisuke1; Ikeno, Masashi2; Kamiya, Megumi2; Suzuki, Nobutaka2; Horiguchi, Akihiko1; Nagata, Hideo1; Yamamoto, Toshiyuki1; Kobayashi, Naoya3; Fox, Ira J.4; Okazaki, Tsuneko2; Miyakama, Syuichi1
Source: Cell Transplantation, Volume 17, Numbers 1-2, 2008 , pp. 165-171(7)
Publisher: Cognizant Communication Corporation
Abstract:The shortage of organ donors has impeded the development of human hepatocyte transplantation. Immortalized hepatocytes could provide an unlimited supply of transplantable cells. To determine whether immortalized hepatocytes could provide global metabolic support in end-stage liver disease, rat hepatocyte clones were developed by transduction with the gene encoding the Simian virus 40 T antigen (SVT) using the human artificial minichromosome (HAC). The SVLT sequence was excised by FRT recombination. Following HAC infusion, the transduced hepatocytes express SVT, blasticidine resistance (BS), and the PGK promoter TK gene. Forty-six cell clones were obtained and at least partially characterized, as previously described, for albumin, α-1-antitrypsin, glucose-6-phosphatase (G6Pase), dipeptidylpeptidase 4 (Dpp4), -glutamyltransferase 1 (Ggt), SVT, and -actin expression using RT-PCR. Clones were also assessed for albumin secretion into the culture medium using ELISA. All of the cell line secreted approximately 10 mg/dl of albumin, which is equivalent to the amount secreted by primary hepatocytes. In further experiments, this cell line will be used for transplantable cells or artificial organ using HAC. These results represent an important step toward the development of immortalized hepatocytes.
Document Type: Research Article
Affiliations: 1: Department of Surgery, Fujita-Health University, Toyaoke City, Aichi, Japan 2: Institute for Comprehensive Medical Science, Fujita-Health University, Toyoake City, Aichi, Japan 3: Department of Surgery, Okayama University, Okayama, Japan 4: Department of Surgery, University of Nebraska Medical Center, Omaha, NE, USA
Publication date: 2008-01-01
- Cell Transplantation publishes original, peer-reviewed research and review articles on the subject of cell transplantation and its application to human diseases. To ensure high-quality contributions from all areas of transplantation, separate section editors and editorial boards have been established. Articles deal with a wide range of topics including physiological, medical, preclinical, tissue engineering, and device-oriented aspects of transplantation of nervous system, endocrine, growth factor-secreting, bone marrow, epithelial, endothelial, and genetically engineered cells, among others. Basic clinical studies and immunological research papers are also featured. To provide complete coverage of this revolutionary field, Cell Transplantation will report on relevant technological advances, and ethical and regulatory considerations of cell transplants. Cell Transplantation is now an Open Access journal starting with volume 18 in 2009, and therefore there will be an inexpensive publication charge, which is dependent on the number of pages, in addition to the charge for color figures. This will allow work to be disseminated to a wider audience and also entitle the corresponding author to a free PDF, as well as prepublication of an unedited version of the manuscript.
- In this: publication
- By this: publisher
- In this Subject: Anatomy & Physiology , Biology , Biotechnology , Pharmacology , Surgery
- By this author: Ito, Masahiro ; Ito, Ryoutaro ; Yoshihara, Daisuke ; Ikeno, Masashi ; Kamiya, Megumi ; Suzuki, Nobutaka ; Horiguchi, Akihiko ; Nagata, Hideo ; Yamamoto, Toshiyuki ; Kobayashi, Naoya ; Fox, Ira J. ; Okazaki, Tsuneko ; Miyakama, Syuichi